Literature DB >> 26645765

Effect of Native Gastric Mucus on in vivo Hybridization Therapies Directed at Helicobacter pylori.

Rita S Santos1,2,3,4, George R Dakwar2, Ranhua Xiong2,5, Katrien Forier2,5, Katrien Remaut2, Stephan Stremersch2, Nuno Guimarães1,3,4,6, Sílvia Fontenete1,3,4,6,7, Jesper Wengel6, Marina Leite3,4, Céu Figueiredo3,4,8, Stefaan C De Smedt2, Kevin Braeckmans2,5, Nuno F Azevedo1.   

Abstract

Helicobacter pylori infects more than 50% of the worldwide population. It is mostly found deep in the gastric mucus lining of the stomach, being a major cause of peptic ulcers and gastric adenocarcinoma. To face the increasing resistance of H. pylori to antibiotics, antimicrobial nucleic acid mimics are a promising alternative. In particular, locked nucleic acids (LNA)/2'-OMethyl RNA (2'OMe) have shown to specifically target H. pylori, as evidenced by in situ hybridization. The success of in vivo hybridization depends on the ability of these nucleic acids to penetrate the major physical barriers-the highly viscoelastic gastric mucus and the bacterial cell envelope. We found that LNA/2'OMe is capable of diffusing rapidly through native, undiluted, gastric mucus isolated from porcine stomachs, without degradation. Moreover, although LNA/2'OMe hybridization was still successful without permeabilization and fixation of the bacteria, which is normally part of in vitro studies, the ability of LNA/2'OMe to efficiently hybridize with H. pylori was hampered by the presence of mucus. Future research should focus on developing nanocarriers that shield LNA/2'OMe from components in the gastric mucus, while remaining capable of diffusing through the mucus and delivering these nucleic acid mimics directly into the bacteria.

Entities:  

Year:  2015        PMID: 26645765      PMCID: PMC5014538          DOI: 10.1038/mtna.2015.46

Source DB:  PubMed          Journal:  Mol Ther Nucleic Acids        ISSN: 2162-2531            Impact factor:   10.183


Introduction

Helicobacter pylori is a stomach-colonizing Gram negative bacterium that infects more than half of the world's population.[1,2] Because it increases the susceptibility to gastric cancer, associated with one of the highest mortality rates,[3] it is classified as a Group 1 carcinogen by the World Health Organization.[4] Moreover, it is associated with 95% of duodenal ulcers and 80% of gastric ulcers.[5] H. pylori colonizes almost exclusively the stomach, lying deep in the mucus layer that covers the gastric epithelium,[6] and also adhering to the surface of gastric epithelial cells and in deeper regions of the gastric glands ().[7,8,9] The prevailing treatment for H. pylori eradication relies on a standard triple therapy, involving two antibiotics (clarithromycin plus amoxicillin or metronidazole) combined with a proton pump inhibitor.[10,11] Even with this triple therapy, full eradication fails in nearly 25% of the patients.[12,13] This is caused by (i) the highly acidic gastric pH the drugs need to endure, (ii) the very viscous mucus the drugs have to permeate,[14] and (iii) the rising resistance of H. pylori to antibiotics.[15] Therefore, alternative treatments are of utmost importance. To fulfil this need, antisense antibacterial therapy, through the use of oligonucleotides to inhibit the expression of essential bacterial genes, is a promising strategy.[16,17,18] An attractive aspect of this approach is its flexibility. In case microbial resistance emerges, commonly by point mutations,[19] the oligonucleotides can be easily redesigned to target a new mutation, becoming an effective antibacterial again. Conventional DNA oligonucleotides have relatively low affinity toward RNA and DNA complementary sequences and are susceptible to degradation by endonucleases.[20,21] To overcome these drawbacks, nucleic acid mimics (NAMs), have emerged as alternatives.[20,22] Among them, locked nucleic acids (LNA), 2'-Omethyl RNA (2'OMe) and phosphorothioate modified oligonucleotides () have shown the most promising antisense in vivo.[23,24,25,26,27] While nucleic acid therapy of bacterial infections is a relatively unexplored field,[18] delivery of oligonucleotides in bacteria is well studied to detect microorganisms based on fluorescence in situ hybridization (FISH). FISH () is based on specific base pairing, at high temperature, of an oligonucleotide with rRNA or mRNA target sequences, obeying to Watson-Crick hydrogen-bonding.[28,29,30,31] Recently, Fontenete et al.[32] have proven that oligonucleotides composed of both LNA and 2'OMe (which we term LNA/2'OMe), with either phosphodiester (PO) or phosphorothioate (PS) as backbone linkages, allow specific detection of H. pylori. In this work, well-reported agents to permeabilize the bacterial cell envelope (like paraformaldehyde and ethanol) were used; H. pylori both grown in culture as well as in gastric biopsies could be detected in this way at 37 °C. In addition, very recently, H. pylori detection by LNA/2'OMe (PS) oligonucleotides was successful even at a gastric pH and without the use of paraformaldehyde.[33] However, the presence of gastric mucus was not addressed in these hybridization experiments. Clearly, the success of in vivo hybridization (IVH) for treating H. pylori infection depends on the ability of the NAMs to overcome two main barriers: the gastric mucus and the bacterial cell envelope (). Gastric mucus is a highly complex and viscoelastic mixture that forms a major protective barrier for the penetration of particles.[34] The rheological properties of the mucus are mostly determined by mucins, the main component of dry mucus, but also affected by the lipids, DNA, cells and cellular debris, proteins and ions present.[34,35,36,37] Having crossed the mucus layer, the next barrier encountered by the oligonucleotides will be the cell envelope of H. pylori. Unlike eukaryotic cells, which possess only a cell membrane, bacteria are protected from the outer environment by a multilayered cell envelope, composed of an inner membrane, periplasm, peptidoglycan layer and, in case of Gram negative bacteria, an outer membrane.[38] Traditional FISH employs permeabilization agents to allow oligonucleotides to reach the cytoplasm.[30] As these agents are typically toxic or noxious,[39,40] this step should be circumvented in future IVH therapies. Considering the potential of IVH for treating H. pylori infection, we studied to which extent gastric mucus may be a barrier for the delivery of oligonucleotides. More specifically, we studied (i) the (chemical) stability of LNA/2'OMe oligonucleotides in native gastric mucus scrapped off from porcine stomachs, (ii) the diffusion of LNA/2'OMe oligonucleotides, PO and PS, through the mucus, and (iii) the effect of gastric mucus on the efficiency of the fluorescence in situ hybridization in H. pylori. On top, we revealed to which extent the bacterial cell envelope is a barrier for the uptake of LNA/2'OMe oligonucleotides. Our experiments disclose important insights which will be of interest for the further development of gastric IVH therapies.

Results

NAMs uptake by H. pylori without prior permeabilization

For future H. pylori IVH therapy, fixation and permeabilization of bacteria should be avoided as the reagents used are toxic or noxious. Therefore, we investigated the hybridization efficiency of LNA/2'OMe oligonucleotides without fixation/permeabilization of the bacteria (). The hybridization was rather efficient, as nearly 50% (PS) and 70% (PO) of the fluorescence of the fully fixed/permeabilized bacteria (treatment with both paraformaldehyde and ethanol) was achieved (). The treatment with ethanol alone did not have a real benefit. In , the hybridization and washing steps were performed at pH 7. In an in vivo setting, however, the hybridization will have to happen within the gastric mucus; note that the mucus samples we isolated from pigs showed an average pH of 5.8. In addition, highly acidic gastric juice in the gastric lumen (upwards the gastric mucus) might contribute to wash away free NAMs. Therefore, we performed hybridization experiments at pH 5.8, followed by washing using simulated gastric juice (pH 1.8), instead of water (). It was verified that an efficient uptake of the NAMs occurred without fixation/permeabilization at neutral pH 7 (), as well as in conditions at pH closer to the in vivo ().

Diffusion of NAMs in native gastric mucus

Fluorescence recovery after photobleaching (FRAP) was used to measure the diffusion of both LNA/2'OMe oligonucleotides in native porcine gastric mucus (). As shows, when compared to 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) buffer, the diffusion in gastric mucus was slowed down, especially for the PS oligonucleotides. As the f values reveal in , all PO oligonucleotides are mobile in mucus, while a small fraction of the PS oligonucleotides becomes immobilized by the gastric mucus. Visual inspection of the microscopy images also showed a more heterogeneous distribution in mucus of PS, when compared to PO (Supplementary Figure S1 and Supplementary Movies in Supplementary Material).

Stability of NAMs in native gastric mucus

Polyacrylamide gel electrophoresis (PAGE) experiments reveal that both PO and PS oligonucleotides are stable in gastric mucus (). The faster diffusion of the PO in mucus, compared to the PS oligonucleotides (as seen in ), cannot be attributed to its enzymatic degradation, since it is stable and DNase and RNase resistant (). Comparing each oligonucleotide in water and in mucus, we observed that gastric mucus “smeared” the oligonucleotides over the gel, thereby reducing the intensity of the oligonucleotide band (); this smearing was more pronounced in case of the PS oligonucleotides. Similar results were obtained using mucus from two other pigs. When incubating the oligonucleotides in a (commercial) mucin dispersion, the same trend was noticed (), although the smearing of the oligonucleotides was less pronounced. The PAGE results suggest that the NAMs interact with mucus components, likely mucins. In agreement with the outcome of the FRAP experiments (f values in ), the PS oligonucleotides seem to adhere more strongly to gastric mucus than the PO oligonucleotides.

H. pylori hybridization in native gastric mucus

To find out whether the interactions between NAMs and mucus, as observed above, could affect the ability of NAMs to hybridize in H. pylori, FISH was performed with and without mucus in the hybridization step. Additionally, for each of these conditions, we tested both PAR-ETH treated and untreated bacteria (ETH treated was not considered at this stage, since it did not previously show a real effect on NAMs uptake). As shown in , the presence of native gastric mucus significantly decreased the hybridization efficiency of both NAMs, in fixed/permeabilized and untreated H. pylori. When using fixed/permeabilized H. pylori, a lower efficiency was noticed for PS than PO, in line with the previously observed stronger interaction of PS to mucus. This was not, however, reflected in untreated H. pylori (, orange bars). Also the mucin dispersion reduced the hybridization efficiency, but much less than native mucus (PS presented 55% and PO 50% of the positive control's fluorescence), suggesting that mucin molecules alone do not fully explain the decreased hybridization in gastric mucus.

Discussion

LNA and 2'OMe oligonucleotides are promising nucleic acid mimics for novel gene therapies, due to their biological stability and improved target affinity, compared to unmodified variants.[25] Following the discovery of two LNA/2'OMe oligonucleotides, one further modified with PS internucleotide linkages and another possessing normal PO linkages, able to specifically target H. pylori at human body temperature,[32] the present work aimed to reveal whether the LNA/2'OMe oligonucleotides hold promise to be used in vivo as antisense strategy against H. pylori infections. Therefore, we investigated if LNA/2'OMe oligonucleotides can hybridize in H. pylori in the presence of native gastric mucus, without prior permeabilization and fixation of the bacteria. First, we investigated if LNA/2'OMe can penetrate the bacterial cell envelope without prior permeabilization and fixation, employing FISH without mucus. Paraformaldehyde and ethanol are among the most common permeabilization and fixation agents.[1,21,30,31,41,42,43] While paraformaldehyde is a fixative, ethanol acts both as a fixative and permeabilizer of the bacterial membrane lipids.[44,45] Fixation and permeabilization agents cannot, however, be used for in vivo applications due to their toxicity.[44] Our results showed successful hybridization of LNA/2'OMe oligonucleotides in untreated H. pylori, not only when hybridization and washing were performed at pH 7 (), but also under pH conditions representative for the in vivo gastric environment (). These findings are in line with a previous report, where it was shown that FISH targeting of bacterial rRNA can be performed without fixation for identification of bacteria in enhanced biological phosphorus removal sludge samples.[46] Since the presence of ethanol by itself did not show a clear advantage in our hands (), it can be concluded that permeabilization of the H. pylori envelope is not needed for the penetration of the LNA/2'OMe tested. The relatively small size of the oligonucleotides (10 mers) is certainly an advantage. One has to note, however, that the combined use of paraformaldehyde and ethanol did result in a stronger fluorescence of the bacteria (,c). This may be due to a stronger fixative effect of paraformaldehyde compared to ethanol, providing better preservation of ultrastructures, proteins and nucleic acids and a longer maintenance of the fluorescence, especially for gram negative bacteria.[44,45,47] Next, we investigated the mobility and stability of LNA/2'OMe in native porcine gastric mucus. So far the presence of mucus has been neglected in relation to the delivery of macromolecules and antibiotics to H. pylori.[12,48,49,50] On the other hand, several studies considering macromolecules/particles diffusion in mucus use mimic models based on commercial mucins or mixtures thereof,[51,52,53,54] which are still far from the real native gastric mucus. By PAGE, we could confirm the integrity of both oligonucleotides in native gastric mucus. In addition, by FRAP we found that gastric mucus is not a major diffusion barrier for the oligonucleotides, although the diffusion of PS in mucus was three times slower than in HEPES buffer, while for PO it was 1.2 times slower (DPS = 58.1 ± 8.1 µm2/s and DPO = 161.6 ± 8.0 µm2/s). This difference should not be attributed to the oligos' size (since they differ only in 0.15 kDa), but to the presence of the thioate group (PS). This might lead to more or stronger interactions of oligo PS with mucus components, likely mucins, since a similar interaction trend was observed in a suspension of commercial mucins, by PAGE. In any case, assuming an average thickness of the gastric mucus layer of 180 µm,[34] according to Equation 1 this means that crossing this layer would take only 2 minutes for PO and less than 5 minutes for PS. t being the time, L the thickness of mucus layer, and D the diffusion coefficient. Therefore, we conclude that the oligonucleotides are sufficiently mobile in gastric mucus and can easily reach the bacteria which are present in the deeper layers of the mucus, adhered to the gastric epithelium. In the presence of gastric mucus, the hybridization in H. pylori was significantly hampered for both types of oligonucleotides (,b), even at longer hybridization time (90 minutes instead of 30 minutes; results not shown), ruling out the possibility of diffusion being the limiting factor—even though that is not expected from the FRAP diffusion measurements. It is clear that the mucus effect on hybridization was not masked by the dilution upon mixing with the oligonucleotides solution; actually, a relevant dilution may also occur in vivo, especially if a common administration by oral gavage is used. Hybridization within mucus must be hindered by interactions of the NAMs with mucus. Mucus is a complex mixture, composed mainly of water and mucins, but also cellular debris, lipids, DNA, proteins, ions.[34,37] Mechanisms of NAMs mucoadhesion may include electrostatic interactions and multiple low-affinity intermolecular bonds, as hydrophobic interactions and hydrogen bonds, given the increased amount of proton donors and acceptors in mucus.[55] Adhesion of oligo PS was more evident than PO, likely due to the increased hydrophobicity of PS[56] and possible establishment of disulfide bonds with mucins (mucins are formed by glycoprotein monomers cross-linked by disulfide bonds[34,36,37]), thereby explaining the slower diffusion of PS in mucus compared to PO. Interestingly, replacing mucus by a simple mucin suspension did partially restore hybridization (). This shows that hybridization in mucus is not simply hindered due to interaction of the oligonucleotides with mucins, but rather with other mucus constituents, as well. Although the particular role/identity of mucus components in the interaction with NAMs remains unclear at this time, soluble factors must account for it, as the FRAP experiments did not show substantial immobilization (i.e., f > 0.9). A corollary of the mucin experiment is that clearly a simple mucin dispersion is not a sufficiently accurate model for gastric mucus and may lead to misleading conclusions when used alone. Another factor that might contribute to decreased hybridization in the presence of mucus is that binding of H. pylori to mucins, which has been reported in the colonization of the stomach,[57,58] may decrease its membrane surface area available for the NAMs penetration. Taken together, our study points out that situ hybridization of LNA/2'OMe does not require permeabilization of the cell envelope, which is beneficial towards potential future IVH therapies. On the other hand, while neither NAMs stability is a concern nor their diffusion through native gastric mucus is a major obstacle, binding interactions with mucus components other than mucins reduced the hybridization efficiency. This work reveals the importance of considering the effect of a representative, native, undiluted, gastric mucus on NAMs delivery to mucosal sites. Future work should focus on developing strategies that protect LNA/2'OMe from interacting with mucus components while traveling through the mucus layer. One interesting approach could be the incorporation of LNA/2'OMe into suitable nanocarriers, such as fusogenic liposomes, that shield the oligonucleotides from the environment, while being able to deliver them efficiently into the cells.

Materials and Methods

Isolation of gastric mucus. Native gastric mucus from the stomach of pigs was used in this study, since porcine gastric mucus is considered a suitable model for human gastric mucus.[37,51] Moreover, pigs have a gastric physiology similar to humans, making them representative animal models for studies of Helicobacter infection.[59] Mucus from three different pigs was included in each assay. Stomachs were collected from a slaughterhouse and immediately opened at the major curvature and rinsed with tap water.[60] The mucus from the antrum region was then gently scrapped off using a glass slide and placed in a sterile tube (). Each tube was then aliquoted, placing 200 µl into sterile Eppendorf vials with a sterile plastic syringe, and stored at −80 °C. Synthesis of NAMs. Two oligonucleotides, named HP_LNA/2OMe_PS and HP_LNA/2OMe_PO,[32] complementary to a sequence of the H. pylori 16S rRNA gene, were used in this study. These are composed of LNA and 2'OMe, possess the same sequence and differ only in the internucleotide bonds. One possesses normal phosphodiester oligonucleotides (PO), while the other has one of the two nonbridging oxygen atoms replaced by a sulfur atom at each internucleotide linkage (PS) (). To simplify, these oligonucleotides will be herein designated as PO and PS, respectively. The sequence of PO is 5'-lGmeAmeClTmeAmeAlGmeCmeClC-3', while the sequence of PS is 5'-lG*meA*meC*lT*meA*meA*lG*meC*meC*lC*-3', where “l” represents the LNA monomers, “me” the 2'OMe monomers and * the phosphorothioate linkages. Oligonucleotides labeled at 5' with fluorescein phosphoramidite (FAM, Glen Research, VA) were synthetized and purified according to ref. [32]. The same oligonucleotides labeled at the 5'-terminal with Cy3 were acquired from Eurogentec (Ougrée, Belgium). Measuring the diffusion of NAMs in native gastric mucus by FRAP. Approximately 30 µl of native (undiluted) gastric mucus was taken with a plastic syringe and mixed with 4 µl of 100 µmol/l FAM-labeled PO or PS. The mixture was then placed on a microscopy glass slide sealed with an adhesive spacer (S24735, Secure-Seal, Life Technologies, Paisley, UK) and a cover slip. The sample was placed in a stage top incubation chamber (Tokai Hit, Shizuoka, Japan), to perform measurements at 37 °C. Mucus from three different pigs was tested and for each mucus-NAM sample the diffusion measurements were done in triplicate. Measurements in HEPES buffer were performed as control. FRAP was used to measure the diffusion of the fluorescently labeled oligonucleotides.[61,62] For a detailed description of the FRAP experiments, we refer to a previous publication from our group.[61] The measurements were performed using a Nikon C1si confocal laser scanning microscope (CLSM), equipped with a Plan Apo 10x NA 1.4 objective lens. The 488 nm argon ion laser (CVI Melles Griot, CA) was used for photobleaching and imaging. In brief, a FRAP experiment occurs as follows. Using a strong laser beam the fluorescence in a rectangular area (30 × 30 µm) of the mucus-NAM sample is bleached. Next, using an attenuated laser beam, a time-lapse image series is recorded to visualize the fluorescence recovery in the bleached area which is due to diffusion of the fluorescent NAMs from the (nonbleached) surrounding into the bleached zone (see ). The local diffusion coefficient (D) and the fraction of mobile (f) and immobile oligonucleotides can be calculated by fitting the fluorescence recovery data to a theoretical model (Supplementary Materials and Methods), as developed in our group by Deschout et al. [62] Measuring the stability of NAMs in native gastric mucus by PAGE. Two microliters of 20 µmol/l PS or PO (labeled with FAM) were gently mixed (using a 1,000 µl pipette tip) with approximately 5 µl of porcine gastric mucus and incubated at 37 °C for 10 minutes (the approximate time needed for a FRAP measurement). Loading buffer (2 µl of Ambion gel loading solution, Life Technologies, Paisley, UK) was then mixed with the mucus-NAM sample. FAM-labeled oligonucleotides alone and mucus alone were run as controls on a PAGE gel. Each empty well on the gel was filled with a blank (a mixture of 7 µl milli-Q water and 2 µl of loading buffer). In addition, the stability of PS and PO was tested in a suspension of commercial mucin from porcine stomach (type II, Sigma-Aldrich, Bornem, Belgium). Therefore, PS and PO were incubated in a 3% (w/v) mucin dispersion (in 0.9% (w/v) NaCl solution).[63,64] To investigate the degradation of the oligonucleotides by nucleases, PO was incubated for 2 hours at 37 °C with DNase (TURBO DNase, Life Technologies) and RNase (RNase A, Qiagen Benelux B.V., Venlo, The Netherlands). The reaction mixture contained 4 µl of a 5 µmol/l PO, 1 µl of DNase (2U) or RNase (7U) and 13 µl of the respective supplied reaction buffer. All the samples were loaded onto 20% nondenaturing polyacrylamide gels prepared in 5× TBE buffer. Electrophoresis was performed at 110 V, during 75 minutes. Thereafter, the fluorescently labeled oligonucleotides on the gels were visualized by UV transillumination and gel photography. H. pylori FISH—NAMs uptake and hybridization in native gastric mucus. H. pylori 26695 (ATCC 700392) was grown in trypticase soy agar (TSA) supplemented with 5% sheep blood (Becton Dickinson GmbH, Germany) for 48 hours, at 37 °C, under microaerobic conditions. The biomass was recovered from the plates using sterile saline (0.9% (w/v) NaCl) and diluted to nearly 1 × 106 colony-forming unit (CFU)/ml. Smears were prepared on glass slides (20 µl per slide well) by drying at 37 °C. FISH on slide was performed according to Fontenete et al.[32,33], with slight modifications. The main steps of standard FISH are schematically presented in . For standard fixation/permeabilization, the smears were first immersed in 4% (w/v) paraformaldehyde (Fluka—Sigma-Aldrich) for 10 minutes, followed by 15 minutes in 50% (v/v) ethanol (Fluka—Sigma-Aldrich) and allowed to dry. To test the role of fixation/permeabilization on hybridization efficiency, samples treated only with ethanol, and samples not fixed/permeabilized at all were included. The smears were then covered with 20 µl hybridization solution containing 500 mmol/l urea (Vel—VWR, Haasrode, Belgium), 500 mmol/l Tris-HCl, pH 7 (Sigma-Aldrich), 900 mmol/l NaCl (Sigma-Aldrich), and 400 nmol/l of PS or PO labeled with Cy3. To test the effect of native gastric mucus on hybridization efficiency, approximately 30 µl of gastric mucus was first mixed with 20 µl of hybridization solution, and then applied on the bacteria smear (note that the final concentration of NAMs and hybridization solution applied on the bacteria were kept the same as in standard FISH). Samples were covered with a coverslip, placed in dark moist chambers and allowed to hybridize during 30 minutes, at 37 °C. The coverslips were then removed, together with the mucus mixture (when present). To avoid nonfixed H. pylori to be removed from the slide together with the mucus mixture, slides coated with 0.1% (w/v) Poly-L-lysine (Sigma-Aldrich) were used for better adhesion of H. pylori. The slides were then washed during 15 minutes using warm (37 °C) water at pH 7, allowed to dry and visualized on the microscope. The experiments were performed using gastric mucus from three different pigs, in triplicate. The effect of native gastric mucus was compared with that of a mucin dispersion, by performing hybridization in the presence of a 3% (w/v) suspension of commercial mucin (from porcine stomach), instead of mucus. In addition, the influence of acidic washing with simulated gastric juice without pepsin (sGJ; 0.2% w/v NaCl, 80 mmol/l HCl, pH 1.8, ref. 65) was evaluated, after hybridization at the same average pH found in the collected porcine gastric mucus (pH 5.8). Negative controls using hybridization solution without oligonucleotides, and maintaining the remaining FISH conditions, were performed in all experiments. Microscopy images were acquired using a Nikon TE2000 microscope equipped with a Nikon DS-Qi 1Mc epifluorescence camera and a Plan Apo VC 100 × 1.4 NA oil immersion objective lens (Nikon). Cy3 fluorescence was visualized using a TRITC filter (excitation: 530–560 nm; emission: 590–650 nm, Nikon). The same exposure time and the same intensity of the fluorescent lamp were used for all the samples. For fluorescence quantification, 10–15 images per well were taken randomly, covering all the areas of the slide well. Quantification of H. pylori hybridization. The hybridization efficiency in the different conditions was compared through quantification of the fluorescence intensity. This was done using image processing routines available in Matlab (The MathWorks, Natick, MA). First, bacteria were identified in each image based on an automatically determined intensity threshold. After removal of remaining noise (by selecting areas with a minimum number of pixels), a binary mask was generated that corresponds to the location of bacteria in the image. For the regions within the mask, the fluorescence intensity in the original image was quantified as where int corresponds to the fluorescence intensity of each bacterium, BG the background value and pix the number of pixels of the bacterium. Per condition, 10 to 15 images were analyzed in this fashion from which the average fluorescence intensity was calculated. These absolute values were normalized to the respective positive control of PS or PO, hybridized in hybridization solution and washed with water or sGJ. Statistical analysis. Statistical analysis was performed by GraphPad Prism6 software (GraphPad Software, San Diego, CA). FISH results were analyzed using two-way analysis of variance and Tukey's multiple comparison test, comparing the conditions within the same NAM. FRAP results were analyzed by one-way analysis of variance and Sidak's multiple comparisons test. Significance was set at P ≤ 0.05 (****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05). Figure S1. Confocal images of porcine gastric mucus after mixing with respectively PS and PO oligonucleotides. Images from FRAP experiments prior to bleaching. Supplementary Materials and Methods. Supplementary References. Supplementary movie PS. Representative FRAP movie of PS in native gastric mucus. Supplementary movie PO. Representative FRAP movie of PO in native gastric mucus.
  59 in total

1.  Survival of Bifidobacterium longum immobilized in calcium alginate beads in simulated gastric juices and bile salt solution.

Authors:  K Y Lee; T R Heo
Journal:  Appl Environ Microbiol       Date:  2000-02       Impact factor: 4.792

2.  Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric Glands.

Authors:  Michael Sigal; Michael E Rothenberg; Catriona Y Logan; Josephine Y Lee; Ryan W Honaker; Rachel L Cooper; Ben Passarelli; Margarita Camorlinga; Donna M Bouley; Guillermo Alvarez; Roeland Nusse; Javier Torres; Manuel R Amieva
Journal:  Gastroenterology       Date:  2015-02-26       Impact factor: 22.682

3.  Factors influencing the detection of bacterial cells using fluorescence in situ hybridization (FISH): A quantitative review of published reports.

Authors:  Thierry Bouvier; Paul A Del Giorgio
Journal:  FEMS Microbiol Ecol       Date:  2003-05-01       Impact factor: 4.194

Review 4.  Mucus models to evaluate nanomedicines for diffusion.

Authors:  Anne-Claire Groo; Frederic Lagarce
Journal:  Drug Discov Today       Date:  2014-01-31       Impact factor: 7.851

Review 5.  Exploring alternative treatments for Helicobacter pylori infection.

Authors:  Guadalupe Ayala; Wendy Itzel Escobedo-Hinojosa; Carlos Felipe de la Cruz-Herrera; Irma Romero
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.

Authors:  Peter Malfertheiner; Viola Schultze; Bernd Rosenkranz; Stefan H E Kaufmann; Timo Ulrichs; Deborah Novicki; Francesco Norelli; Mario Contorni; Samuele Peppoloni; Duccio Berti; Daniela Tornese; Jitendra Ganju; Emanuela Palla; Rino Rappuoli; Bruce F Scharschmidt; Giuseppe Del Giudice
Journal:  Gastroenterology       Date:  2008-05-28       Impact factor: 22.682

7.  Bacterial-binding chitosan microspheres for gastric infection treatment and prevention.

Authors:  Inês C Gonçalves; Ana Magalhães; Mariana Fernandes; Inês V Rodrigues; Celso A Reis; M Cristina L Martins
Journal:  Acta Biomater       Date:  2013-08-03       Impact factor: 8.947

Review 8.  Factors that mediate colonization of the human stomach by Helicobacter pylori.

Authors:  Ciara Dunne; Brendan Dolan; Marguerite Clyne
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

9.  Comparison of Helicobacter mustelae and Helicobacter pylori adhesion to eukaryotic cells in vitro.

Authors:  B D Gold; M Dytoc; M Huesca; D Philpott; A Kuksis; S Czinn; C A Lingwood; P M Sherman
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

10.  Development and application of a novel peptide nucleic acid probe for the specific detection of Helicobacter pylori in gastric biopsy specimens.

Authors:  N Guimarães; N F Azevedo; C Figueiredo; C W Keevil; M J Vieira
Journal:  J Clin Microbiol       Date:  2007-07-03       Impact factor: 5.948

View more
  3 in total

1.  Optimizing locked nucleic acid/2'-O-methyl-RNA fluorescence in situ hybridization (LNA/2'OMe-FISH) procedure for bacterial detection.

Authors:  Andreia S Azevedo; Inês M Sousa; Ricardo M Fernandes; Nuno F Azevedo; Carina Almeida
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

Review 2.  Early appropriate diagnostics and treatment of MDR Gram-negative infections.

Authors:  Matteo Bassetti; Souha S Kanj; Pattarachai Kiratisin; Camilla Rodrigues; David Van Duin; María Virginia Villegas; Yunsong Yu
Journal:  JAC Antimicrob Resist       Date:  2022-09-13

3.  Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus.

Authors:  Ying-Ying Wang; Holly A Schroeder; Kenetta L Nunn; Karen Woods; Deborah J Anderson; Samuel K Lai; Richard A Cone
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.